Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Prescription Drug Overdose

PSR | 2013



Deaths from prescription drug overdoses, particularly overdoses of prescription painkillers, have skyrocketed over the past decade.  CDC and other agencies are working to identify and evaluate interventions to reduce overdose deaths. The Prevention Status Reports (PSRs) focus on policies and practices supported by emerging evidence, expert consensus, and/or extensive review of the primary drivers of the epidemic.

The PSRs highlight—for all 50 states and the District of Columbia—the status of two key practices that states can use to reduce prescription drug overdose:


Policies & Practices

State pain clinic law

A pain clinic law is rated green in the PSR if the law requires state oversight and contains other requirements concerning ownership and operation of pain management clinics, facilities, or practice locations.

Research shows that a small number of high-volume prescribers contribute disproportionately to the prescription drug overdose epidemic.2 Not all high-volume prescribers are prescribing for illegitimate reasons, so pain clinic laws are designed to target those clinics where drugs are prescribed inappropriately. Pain clinic laws hold promise for stopping doctor shopping and the most egregious overprescribing.

Status of state pain clinic laws, United States (as of July 2013)


Bar chart showing Status of state pain clinic laws, United States (as of July 2013). Green: 11 states had a pain clinic law meeting selected criteria. Red: 40 states had no pain clinic law. (State count includes the District of Columbia.)
(State count includes the District of Columbia.)


± How the ratings were determined

Pain clinic laws are relatively new, and only 11 states had passed pain clinic legislation as of July 2013. Because of this, states are rated only on a two-tier scale, green or red, according to the following criteria:

Green

As of July 2013, the state had a pain clinic law that required state oversight and contained other requirements concerning ownership and operation of pain management clinics, facilities, or practice locations.

Red

As of July 2013, the state did not have a pain clinic law.

± More information on this indicator

 

Prescription drug monitoring programs following selected best practices

State prescription drug monitoring programs (PDMPs) track the prescribing and dispensing of controlled substances. State PDMPs show early signs of changing providers’ prescribing practices and can yield valuable information for healthcare providers and regulatory agencies.

The PDMP Center of Excellence at Brandeis University has identified selected best practices that PDMPs should follow.3 These include

  1. Providing prescribers and dispensers access to PDMPs
  2. Demonstrating interoperability with the PDMP of at least one other state
  3. Proactively reporting to law enforcement and regulatory agencies

Status of state PDMPs following selected best practices, United States (as of July 2013)


Bar chart showing Status of state PDMPs following selected best practices, United States (as of July 2013). Green: 8 states had a PDMP that followed all three selected best practices. Yellow: 38 states had a PDMP that followed one or two selected best practices. Red: 5 states had a PDMP that did not follow any selected PDMP best practices, was authorized but was not yet operating, or did not exist. (State count includes the District of Columbia.)
(State count includes the District of Columbia.)


± How the ratings were determined

These rating scales are based on selected practices identified by the PDMP Center of Excellence at Brandeis University in its assessment of best practices for PDMPs.

Green

As of 2013, the state had a PDMP that followed all three selected best practices.

Yellow

As of 2013, the state had a PDMP that followed one or two of the selected best practices.

Red

As of 2013, the state had no PDMP, had authorized a PDMP that was not yet in operation, or had a PDMP that did not follow any selected best practices.

± More information on this indicator

 

Prevention Status Reports: Prescription Drug Overdose, 2013

The files below are PDFs ranging in size from 100K to 500K.

Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming


References

  1. CDC. National Vital Statistics System [database]. Accessed Dec 10, 2012.
  2. Office of National Drug Control Policy. Epidemic: Responding to America’s Prescription Drug Abuse Crisis [PDF - 306KB]. Washington, DC: Executive Office of the President of the United States; 2011.
  3. PDMP Center of Excellence. Prescription Drug Monitoring Programs: An Assessment of the Evidence for Best Practices [PDF - 1.1MB]. Waltham, MA: Brandeis University; 2012.

 

 

 
Contact Us:
  • Centers for Disease Control and Prevention
  • Office for State, Tribal, Local and Territorial Support
  • Mailstop: E-70
    4770 Buford Highway, NE
    Atlanta, GA 30341
  • Email OSTLTS
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #